Pro 2013-011 (Announcement on Resolution of 6th Board of Supervisors of Jianfeng Group's 7th Session)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2013-011
Zhejiang Jianfeng Group Co., Ltd.
Announcement of Resolutions of the Sixth Meeting of the Seventh Board of Supervisors
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
On April 8, 2013, Zhejiang Jianfeng Group Co., Ltd. issued a notice to convene the sixth meeting of the seventh board of supervisors by fax, e-mail, telephone, and personal delivery. On April 19, 2013, the meeting was held as scheduled in the conference room of Jianfeng Building in Jinhua, Zhejiang. All five members of the board of supervisors attended the meeting. the meeting was presided over by Mr. Li ziqiang, chairman of the board of supervisors. after deliberation and voting, the following resolutions were passed:
1. the board of supervisors carefully reviewed the 2012 annual report and its summary
and held that:
( 1 ) annual report preparation and review procedures comply with laws, regulations, articles of association and the company's internal management system;
(2) The content and format of the annual report comply with the regulations of the China Securities Regulatory Commission and the stock exchange, the information contained truly reflects the operation, management and financial status of the company in 2012 from all aspects.
(3) No issue The personnel who participated in the preparation and review of the annual report have violated the confidentiality provisions .
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
2, passed the 2012 financial final accounts report
meeting after deliberation and voting, passed the bill. Agree to submit to the general meeting of shareholders for consideration.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
3, passed the 2012 work report of the company's board of supervisors
. The meeting considered that the report fully reflected the work of the board of supervisors in 2012 and agreed to submit it to the shareholders' meeting for deliberation.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
4. Proposal on Asset Write-off
was passed after deliberation and voting.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
5, passed the daily related party transaction motion
meeting after deliberation and voting, passed the motion.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
. The 2012 Internal Control Self-evaluation Report
was passed. After deliberation and voting, the proposal was passed.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
This is to announce
April 23, 2013
Supervisory Board of Zhejiang Jianfeng Group Co., Ltd.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page